Vanderbilt football's Diego Pavia, who won an NCAA lawsuit, and Eli Stowers, a potential NFL draft prospect, return for 2025.

Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

Representative Eli Crane (R-AZ) says the public looks forward to hearing President Donald Trump talk about his administration’s progress on border security and the economy during his speech to a joint ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its ...

Tonight's featured guest will be Arizona GOP Rep. Eli Crane. Also appearing will be Texas GOP Rep. Michael Cloud; Retired FBI ...

Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

The brothers who run AB & Sons refinanced 447 Broadway in Soho, dodging distress lender’s aggressive foreclosure ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

Some of the 2025 trends that are sticking around from previous years are the use of curves in furniture, color drenching ...